| 标题 |
Design of Two Randomized, Placebo-Controlled, Phase 3 Trials of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Systemic Lupus Erythematosus |
| 网址 | |
| DOI | |
| 其它 |
期刊:Advances in Therapy 作者:Cristina Arriens; Eric F. Morand; Anca Askanase; Richard Furie; Ronald van Vollenhoven; et al 出版日期:2025-09-08 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)